Upadacitinib/ABBV-105 |
ABBV-599 |
Phase 2 Clinical |
Abbvie Inc |
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic |
Details
|
WXFL10203614 |
WXFL-10203614; WXFL10203614 |
Phase 2 Clinical |
Wuxi Apptec Co Ltd, Wuxi Fuxin Pharmaceutical Research And Development Co Ltd |
Arthritis, Rheumatoid |
Details
|
AZD-4205 |
NC-0322; AZD-4205; DZD-4205 |
Phase 2 Clinical |
Astrazeneca Plc, Dizal (Jiangsu) Pharmaceutical Co Ltd |
Lymphoma, T-Cell, Peripheral; Inflammatory Bowel Diseases; Autoimmune Diseases; Carcinoma, Non-Small-Cell Lung |
Details
|
ATI-502 |
A-301; ATI-502; ATI-50002 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Alopecia; Alopecia Areata; Dermatitis, Atopic |
Details
|
ATI-501 |
A-201; ATI-501; ATI-50001 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Alopecia |
Details
|
ATI-1777 |
|
Phase 2 Clinical |
Aclaris Therapeutics Inc |
Dermatitis, Atopic |
Details
|
Deuterated Ruxolitinib |
CTP-543 |
Phase 3 Clinical |
Concert |
Alopecia; Alopecia Areata; Primary Myelofibrosis |
Details
|
ARQ-252 |
ARQ-252 |
Phase 2 Clinical |
Arcutis |
Eczema |
Details
|
Brepocitinib |
PF-841; PF-6700841; PF-06700841; PF-06700841-15 |
Phase 2 Clinical |
Pfizer Inc |
Alopecia; Alopecia Areata; Kidney Diseases; Psoriasis; Lupus Erythematosus, Systemic; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Dermatitis, Atopic; Vitiligo; Crohn Disease |
Details
|
Itacitinib |
IBI-377; INCB-39110; INCB-039110; INCB-039110-adipate |
Phase 3 Clinical |
Incyte Corp |
Graft vs Host Disease; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Lymphoma; Endometrial Neoplasms; Lung Neoplasms; Primary Myelofibrosis; Colorectal Neoplasms; Colitis, Ulcerative; Breast Neoplasms; Thrombocytosis; Psoriasis; Lymphoma, B-Cell; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Hodgkin Disease; Neoplasms; Arthritis, Rheumatoid; Carcinoma, Renal Cell; Polycythemia Vera; Cytokine Release Syndrome; Head and Neck Neoplasms; Solid tumours; Hematologic Neoplasms |
Details
|
Abrocitinib |
PF-4965842; PF-04965842 |
Phase 3 Clinical |
Pfizer Inc |
Kidney Diseases; Genetic Diseases, Inborn; Skin Diseases; Dermatitis; Skin Diseases, Eczematous; Psoriasis; Hepatic Insufficiency; Hypersensitivity, Immediate; Dermatitis, Atopic; Skin Diseases, Genetic; Hypersensitivity; Eczema |
Details
|
INCB-054707 |
INCB-54707; INCB54707; INCB054707; INCB-054707 |
Phase 2 Clinical |
Incyte Corp |
Hidradenitis Suppurativa |
Details
|
SHR-0302 |
SHR-0302 |
Phase 3 Clinical |
Jiangsu Hengrui Medicine Co Ltd |
Alopecia Areata; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Colitis, Ulcerative; Hepatic Insufficiency; Dermatitis, Atopic; Crohn Disease; Vitiligo |
Details
|
CS-12192 |
CS12192 |
Phase 1 Clinical |
Shenzhen Chipscreen Biosciences Co Ltd |
Enteritis; Alopecia Areata; Arthritis, Rheumatoid; Graft vs Host Disease; Autoimmune Diseases; Multiple Sclerosis; Lupus Erythematosus, Systemic; Dermatitis, Atopic |
Details
|
Momelotinib Dihydrochloride |
CYT-387; GS-0387 |
Phase 3 Clinical |
Gilead Sciences Inc |
Polycythemia Vera; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Thrombocythemia, Essential |
Details
|
Jaktinib hydrochloride |
|
Phase 3 Clinical |
Suzhou Zelgen Biosciences Co Ltd |
Polycythemia Vera; Alopecia Areata; Idiopathic Pulmonary Fibrosis; Spondylitis, Ankylosing; Psoriasis; Primary Myelofibrosis; Thrombocythemia, Essential; Dermatitis, Atopic; Plaque psoriasis |
Details
|